Prescription peptide therapy. Coming soon.
When the FDA finalizes the 2026 reclassification, 14 peptides will return to legal compounding status. Valitide is building the platform to prescribe them through licensed providers and pharmacies.
These peptides are not yet available for prescription. They are currently classified as Category 2 under FDA rulemaking and cannot be legally compounded. Valitide will offer prescription access once the reclassification is finalized. Learn more →
Recovery & Repair
BPC-157
Body Protection Compound-157
Gastric pentadecapeptide studied for tissue repair, gut healing, and tendon/ligament recovery. One of the most clinically promising peptides in the reclassification pipeline.
TB-500
Thymosin Beta-4 Fragment
A fragment of Thymosin Beta-4 studied for its role in cell migration, wound healing, and inflammation modulation. Commonly paired with BPC-157.
Immune Support
Thymosin Alpha-1
Thymosin Alpha-1
A naturally occurring thymic peptide with immunomodulatory properties. Studied for immune regulation and has approved pharmaceutical analogs in over 30 countries.
Growth Hormone Support
CJC-1295
CJC-1295 (with or without DAC)
A growth hormone-releasing hormone (GHRH) analog that stimulates natural GH production. Often combined with Ipamorelin for synergistic effects.
Ipamorelin
Ipamorelin / Tesamorelin
A selective growth hormone secretagogue with a strong safety profile. Tesamorelin is FDA-approved for lipodystrophy and studied for body composition benefits.
AOD-9604
AOD-9604
A modified fragment of human growth hormone (hGH 177-191) studied for fat metabolism without the growth-promoting effects of full GH.
Sermorelin
Sermorelin acetate
A GHRH analog previously FDA-approved for GH deficiency testing. Stimulates the pituitary to produce natural growth hormone.
Cognitive & Neurological
Selank
Selank
A synthetic analog of tuftsin studied for anxiolytic and nootropic effects. Developed at the Russian Academy of Sciences with a well-documented safety profile.
Semax
Semax
A synthetic heptapeptide derived from ACTH studied for neuroprotective and cognitive-enhancing properties. Used clinically in Russia for stroke recovery.
DSIP
Delta Sleep-Inducing Peptide
A neuromodulatory peptide studied for its role in promoting delta-wave sleep, stress adaptation, and circadian rhythm regulation.
Anti-Aging & Longevity
GHK-Cu
GHK-Cu (Copper Peptide)
A naturally occurring tripeptide-copper complex studied for skin regeneration, wound healing, and collagen synthesis. Declines significantly with age.
Epithalon
Epithalon (Epitalon)
A tetrapeptide studied for its effects on telomerase activation and cellular aging. Based on research by Dr. Vladimir Khavinson on pineal gland peptides.
MOTS-c
MOTS-c
A mitochondria-derived peptide studied for metabolic regulation, exercise mimicry, and insulin sensitivity. Sometimes called an “exercise mimetic.”
NAD+
NAD+ (Nicotinamide Adenine Dinucleotide)
A critical coenzyme involved in cellular energy production and DNA repair. Levels decline with age, driving interest in supplementation and IV therapy.
Sexual Health
PT-141
PT-141 (Bremelanotide)
FDA-approved as Vyleesi for hypoactive sexual desire disorder in women. Acts on melanocortin receptors in the brain rather than the vascular system.
Kisspeptin-10
Kisspeptin-10
A neuropeptide that plays a key role in reproductive hormone signaling. Studied for its effects on GnRH, LH, and FSH regulation.
How prescription peptide access will work
Once the FDA reclassification is finalized, the process will mirror our weight loss treatment model.
Consultation
A licensed telehealth provider evaluates your health goals and determines if peptide therapy is appropriate.
Prescription
Your provider writes a prescription for the specific peptide(s) recommended for your needs.
Compounding
A licensed 503A or 503B compounding pharmacy fills your prescription with pharmaceutical-grade compounds.
Ongoing care
Your provider monitors your progress, adjusts protocols, and ensures safe, effective treatment.
Licensed providers only
Every peptide prescription will require evaluation by a licensed physician or nurse practitioner. No self-prescribing, no gray market.
Vetted compounding pharmacies
We partner exclusively with licensed 503A/503B pharmacies that meet USP standards and provide full Certificates of Analysis.
Education-first approach
Valitide started as a peptide education platform. We believe informed patients make better decisions — read our guides before you ever see a provider.
Get notified when peptide therapy launches
Join the waitlist for regulatory updates and early access when prescription peptide therapy becomes available.
No spam \u2014 only real regulatory updates and access announcements.
Valitide is not a healthcare provider and does not provide medical advice, diagnoses, or treatment. The peptides listed on this page are currently classified as Category 2 under FDA rulemaking and cannot be legally compounded or prescribed until formal reclassification is complete. Valitide does not sell, distribute, or facilitate access to any peptide that is not legally available through a licensed pharmacy with a valid prescription. All future prescriptions will be at the sole discretion of a licensed provider.